Trials / Completed
CompletedNCT01035567
Safety and Efficacy Study of Hybrid Revascularization in Multivessel Coronary Artery Disease
Prospective Randomised Pilot Study Evaluating the Safety and Efficacy of Hybrid Revascularization in Multivessel Coronary Artery Disease
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Silesian Centre for Heart Diseases · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to assess the safety and efficacy of hybrid revascularization in comparison with coronary artery bypass grafting among patients with multivessel coronary artery disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Hybrid revascularization | First stage: implantation of the internal mammary artery into LAD in MIDCAB/TECAB procedure Second stage: PCI with drug eluting stents in other coronary arteries qualified for revascularization within 36 hours after surgery |
| PROCEDURE | Coronary Artery Bypass Grafting | Coronary artery bypass grafting with sternotomy on or off the pump at discretion of the operator. |
Timeline
- Start date
- 2009-11-01
- Primary completion
- 2013-05-01
- Completion
- 2013-10-01
- First posted
- 2009-12-18
- Last updated
- 2013-12-03
Locations
2 sites across 1 country: Poland
Source: ClinicalTrials.gov record NCT01035567. Inclusion in this directory is not an endorsement.